Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Aug;55(8):1596-608.
doi: 10.1194/jlr.R046300. Epub 2014 Jan 23.

An update on the biology of sphingosine 1-phosphate receptors

Affiliations
Review

An update on the biology of sphingosine 1-phosphate receptors

Victoria A Blaho et al. J Lipid Res. 2014 Aug.

Abstract

Sphingosine 1-phosphate (S1P) is a membrane-derived lysophospholipid that acts primarily as an ex-tracellular signaling molecule. Signals initiated by S1P are transduced by five G protein-coupled receptors, named S1P1-5 Cellular and temporal expression of the S1P receptors (S1PRs) determine their specific roles in various organ systems, but they are particularly critical for regulation of the cardiovascular, immune, and nervous systems, with the most well-known contributions of S1PR signaling being modulation of vascular barrier function, vascular tone, and regulation of lymphocyte trafficking. However, our knowledge of S1PR biology is rapidly increasing as they become attractive therapeutic targets in several diseases, such as chronic inflammatory pathologies, autoimmunity, and cancer. Understanding how the S1PRs regulate interactions between biological systems will allow for greater efficacy in this novel therapeutic strategy as well as characterization of complex physiological networks. Because of the rapidly expanding body of research, this review will focus on the most recent advances in S1PRs.

Keywords: activation; endothelium; immune cells; immunity; migration; nervous system; vascular permeability.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Synthesis and export of S1P. S1P synthesis primarily begins with metabolism of membrane SM. Once synthesized, S1P can be irreversibly degraded to phosphoethanolamine and hexadecenal by S1P lyase, or actively transported out of the cell. Once outside of the cell, S1P is found bound to ApoM or albumin. Spns2, spinster 2.
Fig. 2.
Fig. 2.
Expression of S1PRs and responses by endothelial cells. Endothelial cells express S1P1, S1P2, and S1P3 protein. Endothelial cells may express different S1PRs depending on activation status.
Fig. 3.
Fig. 3.
Expression of S1PRs and responses by cells of the acquired immune system. T cells express S1P1 and S1P4, B cells express S1P1, S1P2, S1P3, and S1P4, and NK cells express S1P1 and S1P5. Cells do not necessarily express all of the illustrated S1PRs at one time, but may have differential expression during different stages of maturation or activation.
Fig. 4.
Fig. 4.
Expression of S1PRs and responses by cells of the innate immune system. Monocytes and/or macrophages express S1P1–4, neutrophils express S1P1, S1P3, and S1P4, eosinophils and MCs express all S1PRs, and DCs express S1P1, S1P3, and S1P4. Cells do not necessarily express all of the illustrated S1PRs at one time, but may have differential expression during different stages of maturation or activation.
Fig. 5.
Fig. 5.
Expression of S1PRs and responses by neural cells. Neural progenitors express S1P1 and S1P2, neurons express S1P1 and S1P3, oligodendrocytes express S1P1 and S1P5, and astrocytes express S1P1 and S1P2. S1P1 couples exclusively to Gαi. S1P2 and S1P3 can couple to Gαi, Gα12/13, or Gαq, and S1P5 can couple to Gαi or Gα12/13. Cells do not necessarily express all of the illustrated S1PRs at one time, but may have differential expression during different stages of maturation or activation.

References

    1. Blaho V. A., Hla T. 2011. Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors. Chem. Rev. 111: 6299–6320. - PMC - PubMed
    1. Schwab S. R., Pereira J. P., Matloubian M., Xu Y., Huang Y., Cyster J. G. 2005. Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients. Science. 309: 1735–1739. - PubMed
    1. Pham T-C. T., Fells J. I., Osborne D. A., North E. J., Naor M. M., Parrill A. L. 2008. Molecular recognition in the sphingosine 1-phosphate receptor family. J. Mol. Graph. Model. 26: 1189–1201. - PMC - PubMed
    1. Chun J., Hla T., Lynch K. R., Spiegel S., Moolenaar W. H. 2010. International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature. Pharmacol. Rev. 62: 579–587. - PMC - PubMed
    1. Schmelz E. M., Crall K. J., Larocque R., Dillehay D. L., Merrill A. H. 1994. Uptake and metabolism of sphingolipids in isolated intestinal loops of mice. J. Nutr. 124: 702–712. - PubMed